Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1965 1
1966 1
1968 1
1976 1
1977 2
1978 1
1979 1
1983 1
1984 2
1986 2
1987 1
1988 1
1989 1
1990 2
1991 4
1992 3
1993 3
1994 1
1995 4
1996 5
1997 6
1998 6
1999 6
2000 4
2001 15
2002 14
2003 25
2004 27
2005 16
2006 20
2007 25
2008 32
2009 29
2010 40
2011 38
2012 35
2013 39
2014 50
2015 42
2016 41
2017 57
2018 40
2019 51
2020 29
2021 26
2022 26
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 17981915

669 results

Results by year

Filters applied: . Clear all
Page 1
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML, Ejbjerg B, Hørslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjødt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard H, Christensen AF, Vallø J, Torfing T, Narvestad E, Thomsen HS, Ostergaard M; CIMESTRA study group. Hetland ML, et al. Ann Rheum Dis. 2009 Mar;68(3):384-90. doi: 10.1136/ard.2008.088245. Epub 2008 Apr 3. Ann Rheum Dis. 2009. PMID: 18388160 Clinical Trial.
Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
Haavardsholm EA, Østergaard M, Hammer HB, Bøyesen P, Boonen A, van der Heijde D, Kvien TK. Haavardsholm EA, et al. Ann Rheum Dis. 2009 Oct;68(10):1572-9. doi: 10.1136/ard.2008.091801. Epub 2008 Nov 19. Ann Rheum Dis. 2009. PMID: 19019893
Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.
Hetland ML, Østergaard M, Stengaard-Pedersen K, Junker P, Ejbjerg B, Jacobsen S, Ellingsen T, Lindegaard H, Pødenphant J, Vestergaard A, Jurik AG, Krogh NS, Hørslev-Petersen K; and The CIMESTRA Study Group*. Hetland ML, et al. Scand J Rheumatol. 2019 Jan;48(1):1-8. doi: 10.1080/03009742.2018.1466362. Epub 2018 Aug 13. Scand J Rheumatol. 2019. PMID: 30101636 Clinical Trial.
669 results